Expertise in
1
conditions

Dr. James E. Wild

Family Medicine
Tri-County Family Medicine Asso PC
1 School St Ste 107, 
Gowanda, NY 
Expertise in
1
conditions
Tri-County Family Medicine Asso PC
1 School St Ste 107, 
Gowanda, NY 

Overview

James Wild is a primary care provider, practicing in Family Medicine in Gowanda, New York.

Dr. Wild is highly rated in 1 condition, according to our data. His clinical expertise encompasses Opioid Induced Constipation, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 7 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in NY

Hospital Affiliations

Brooks-Tlc Hospital System, Inc
Bertrand Chaffee Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Tri-County Family Medicine Asso PC
1 School St Ste 107, Gowanda, NY 14070

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: August 09, 2023
Intervention Type: Drug
Study Drugs: Sodium Hyaluronate, Triamcinolone Hexacetonide
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
PROSPER-FM: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
PROSPER-FM: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Enrollment Status: Completed
Publish Date: June 15, 2023
Intervention Type: Device, Other
Study Phase: Phase 3
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

9 Total Publications

Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies.
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies.
Journal: Journal of pain research
Published: October 13, 2020
Similar Doctors
Expertise in
1
conditions
Dr. Dana P. Anderson
Family Medicine
Expertise in
1
conditions
Dr. Dana P. Anderson
Family Medicine

Tri-County Family Medicine Asso PC

1 School St Ste 107, 
Gowanda, NY 
 (0.1 miles away)
716-241-7067
Languages Spoken:
English
See accepted insurances

Dana Anderson is a primary care provider, practicing in Family Medicine in Gowanda, New York. Dr. Anderson is highly rated in 1 condition, according to our data. His clinical expertise encompasses Diabetic Nephropathy, Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Expertise in
3
conditions
Dr. Spencer Gorsline
Family Medicine
Expertise in
3
conditions
Dr. Spencer Gorsline
Family Medicine

Cattaraugus Indian Reservation Health Center

36 Thomas Indian School Dr, 
Irving, NY 
 (9.1 miles away)
716-532-5582
Languages Spoken:
English
See accepted insurances

Spencer Gorsline is a primary care provider, practicing in Family Medicine in Irving, New York. Dr. Gorsline is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Ascites, End-Stage Renal Disease (ESRD), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Expertise in
0
conditions
Dr. Tariq A. Sheikh
Family Medicine
Expertise in
0
conditions
Dr. Tariq A. Sheikh
Family Medicine

Office

10626 Main St, 
North Collins, NY 
 (12.0 miles away)
716-337-2422
Languages Spoken:
English
See accepted insurances

Tariq Sheikh is a primary care provider, practicing in Family Medicine in North Collins, New York. His clinical expertise encompasses Type 2 Diabetes (T2D), Obesity in Children, High Cholesterol, and Myasthenia Gravis.

Expertise in
0
conditions
Dr. Marcy A. Masyga
Family Medicine
Expertise in
0
conditions
Dr. Marcy A. Masyga
Family Medicine

Office

230 S Cascade Dr, 
Springville, NY 
 (13.0 miles away)
716-592-3600
Languages Spoken:
English
See accepted insurances

Marcy Masyga is a primary care provider, practicing in Family Medicine in Springville, New York. Her clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Expertise in
0
conditions
Dr. Morris M. Cavalieri
Family Medicine
Expertise in
0
conditions
Dr. Morris M. Cavalieri
Family Medicine

Office

10626 Main St, 
North Collins, NY 
 (12.0 miles away)
716-337-2422
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Morris Cavalieri is a primary care provider, practicing in Family Medicine in North Collins, New York. His clinical expertise encompasses Type 2 Diabetes (T2D), Deep Vein Thrombosis, Hypertension, and Familial Hypertension.

Expertise in
0
conditions
Dr. Kathleen P. King
Family Medicine
Expertise in
0
conditions
Dr. Kathleen P. King
Family Medicine

Office

230 S Cascade Dr, 
Springville, NY 
 (13.0 miles away)
716-592-3600
Languages Spoken:
English
See accepted insurances

Kathleen King is a primary care provider, practicing in Family Medicine in Springville, New York. Her clinical expertise encompasses Diabetic Nephropathy, Type 2 Diabetes (T2D), Diabetic Neuropathy, and Chronic Obstructive Pulmonary Disease (COPD).

Frequently Asked Questions about Dr. James E. Wild

How do I make an appointment with Dr. James E. Wild?

You can book an appointment with Dr. James E. Wild by calling their office at 716-241-7067. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James E. Wild a top-rated expert for Opioid Induced Constipation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James E. Wild is classified as an Elite expert for Opioid Induced Constipation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James E. Wild specialize in?

While Dr. James E. Wild is a Family Medicine, they have specific expertise in Opioid Induced Constipation, Familial Combined Hyperlipidemia, and Xanthoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. James E. Wild participate in research or clinical trials?

Yes. Dr. James E. Wild has published 9 articles and abstracts on conditions like Opioid Induced Constipation. You can view a list of Dr. James E. Wild's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James E. Wild accept my insurance?

Dr. James E. Wild accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 716-241-7067 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wild's expertise for a condition
ConditionClose
      View All 29 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile